Hikari Tsushin Inc. Acquires Shares of 4,380 iShares NASDAQ Biotechnology Index (IBB)

Hikari Tsushin Inc. acquired a new stake in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 4,380 shares of the financial services provider’s stock, valued at approximately $468,000.

Several other institutional investors have also added to or reduced their stakes in the business. Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of iShares NASDAQ Biotechnology Index by 200.0% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,907,625 shares of the financial services provider’s stock valued at $203,677,000 after purchasing an additional 1,271,750 shares during the last quarter. Natixis raised its holdings in shares of iShares NASDAQ Biotechnology Index by 631.5% in the first quarter. Natixis now owns 1,150,000 shares of the financial services provider’s stock valued at $122,751,000 after purchasing an additional 992,783 shares during the last quarter. Commerce Bank raised its holdings in shares of iShares NASDAQ Biotechnology Index by 217.0% in the fourth quarter. Commerce Bank now owns 793,250 shares of the financial services provider’s stock valued at $84,695,000 after purchasing an additional 543,005 shares during the last quarter. Meitav Dash Investments Ltd. purchased a new stake in shares of iShares NASDAQ Biotechnology Index in the fourth quarter valued at about $54,468,000. Finally, Alliancebernstein L.P. raised its holdings in shares of iShares NASDAQ Biotechnology Index by 79.6% in the fourth quarter. Alliancebernstein L.P. now owns 1,140,301 shares of the financial services provider’s stock valued at $121,750,000 after purchasing an additional 505,243 shares during the last quarter. 60.10% of the stock is currently owned by hedge funds and other institutional investors.

Shares of IBB stock traded up $0.32 on Thursday, hitting $110.81. The stock had a trading volume of 18,397 shares, compared to its average volume of 2,821,399. iShares NASDAQ Biotechnology Index has a 12-month low of $96.84 and a 12-month high of $119.30.

iShares NASDAQ Biotechnology Index Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply